(R)-3-(1H-Indol-3-yl)-2-(5-(p-tolylethynyl)thiophene-2-sulfonamido)propanoic acid manufacturers
- S 3304
-
- $68.00
-
2026-08-08
- CAS:203640-27-1
- Purity: 98.09%
- Supply Ability: 10g
|
| | (R)-3-(1H-Indol-3-yl)-2-(5-(p-tolylethynyl)thiophene-2-sulfonamido)propanoic acid Basic information |
| Product Name: | (R)-3-(1H-Indol-3-yl)-2-(5-(p-tolylethynyl)thiophene-2-sulfonamido)propanoic acid | | Synonyms: | (R)-3-(1H-Indol-3-yl)-2-(5-(p-tolylethynyl)thiophene-2-sulfonamido)propanoic acid;R-3-(1H-Indol-3-yl)-2-(5-(p-tolyleth ynyl)thiophene-2;(2R)-3-(1H-indol-3-yl)-2-{5-[2-(4-methylphenyl)ethynyl]thiophene-2-sulfonamido}propanoic acid;(2R)-3-(1H-indol-3-yl)-2-[[5-[2-(4-methylphenyl)ethynyl]thiophen-2-yl]sulfonylamino]propanoic acid;D-Tryptophan, N-[[5-[2-(4-methylphenyl)ethynyl]-2-thienyl]sulfonyl]-;(R)-3-(1H-Indol-3-yl)-2-(5-p-tolylethynyl-thiophene-2-sulfonylamino)-propionic acid;S 3304,Inhibitor,inhibit,S3304,MMP,S-3304,Matrix metalloproteinases;S 3304, 10 mM in DMSO | | CAS: | 203640-27-1 | | MF: | C24H20N2O4S2 | | MW: | 464.56 | | EINECS: | | | Product Categories: | | | Mol File: | 203640-27-1.mol |  |
| | (R)-3-(1H-Indol-3-yl)-2-(5-(p-tolylethynyl)thiophene-2-sulfonamido)propanoic acid Chemical Properties |
| Boiling point | 745.7±70.0 °C(Predicted) | | density | 1.47±0.1 g/cm3(Predicted) | | storage temp. | under inert gas (nitrogen or Argon) at 2–8 °C | | solubility | Aqueous Base (Slightly), DMSO (Slightly) | | form | Solid | | pka | 3.29±0.10(Predicted) | | color | Pale Beige to Light Beige |
| | (R)-3-(1H-Indol-3-yl)-2-(5-(p-tolylethynyl)thiophene-2-sulfonamido)propanoic acid Usage And Synthesis |
| Description | S-3304 is a sulfonamide derivative that acts as a matrix metalloproteinase inhibitor. | | Uses | S 3304, is a novel matrix metalloproteinases (MMP) inhibitor specific for MMP-2 and MMP-9. | | in vivo | In vivo pharmacologic studies have shown that the oral administration of S 3304, at a dose range of 20 to 200 mg/kg, inhibits angiogenesis, artificially induced in mice by the dorsal air-sac method. Similar oral doses of S 3304 result in potent inhibition of metastatic lung colonization of Lewis murine lung carcinoma injected via tail vein and liver metastasis of C-1H human colon cancer implanted into the spleen[1]. | | IC 50 | MMP-9 |
| | (R)-3-(1H-Indol-3-yl)-2-(5-(p-tolylethynyl)thiophene-2-sulfonamido)propanoic acid Preparation Products And Raw materials |
|